Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Atypical plasma cholinesterase. A personal discovery story: a tale of three cities

  • 506 Accesses

  • 14 Citations

References

  1. 1

    Garrod AE. Inborn Factors in Disease: an Assay. Oxford University Press; 1931.

  2. 2

    Haidane JBS. Disease and evolution. La Ricerca Scientifica 1949; 19: 68–75.

  3. 3

    Fosdick LS, Hansen HL. A study of the products of metabolism of procain hydrochloride. Dental Cosmos 1931; 73: 1082–4.

  4. 4

    Brodie BB, Lief PA, Poet R. The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethy-laminoethanol. J Pharmacol Exp Ther 1948; 94: 359–66.

  5. 5

    Herken H. Untersuchungen an serumproteinen bei eiweissmangelernahrung. Arztl Wochenschr 1949; 4: 297–302.

  6. 6

    Herken H, Kalow W. Photometometrische bestimmung der enzymatischen novocain-hydrolyse. Klin Wochenschr 1951; 29: 90–1.

  7. 7

    Aviado DM Jr, Li TH, Kalow W, et al. Respiratory and circulatory reflexes from the perfused heart and pulmonary circulation of the dog. Am J Physiol 1951; 165: 261–77.

  8. 8

    Mendel B, Rudney H. Studies on cholinesterase. I. Cholinesterase and pseudocholinesterase. Biochem J 1943; 37: 59–63.

  9. 9

    Kalow W. Hydrolysis of local anesthetics by human serum cholinesterase. J Pharmacol Exp Ther 1952; 104: 122–34.

  10. 10

    Kalow W, Lindsay HA. A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Biochem Physiol 1955; 135: 568–74.

  11. 11

    Bovet-Nitti F. Degradazione di alcune sostanze curarizzanti per azione di cholinesterasi. R C 1st sup Sanita 1949; 12: 138–57.

  12. 12

    Kalow W, Genest K A. method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers. Can J Biochem Physiol 1957; 35: 339–46.

  13. 13

    Kalow W, Staron N. On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem Physiol 1957; 35: 1305–20.

  14. 14

    Kalow W, Gunn DR. The relation between dose of succinylcholine and duration of apnea in man. J Pharmacol Exp Ther 1957; 120: 203–6.

  15. 15

    Lehmann H, Ryan E. The familial incidence of low pseudocholinesterase level. Lancet 1956; 2: 126.

  16. 16

    Kalow W. Familial incidence of low pseudo-cholinesterase level. Lancet 1956; 2: 576–7.

  17. 17

    Jensen FS, Schwartz M, Viby-Mogensen J. Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand 1995, 39: 142–9.

  18. 18

    Beutler E. The molecular biology of G6PD variants and other red cell enzyme defects. Annu Rev Med 1992; 43: 47–59.

  19. 19

    Bonicke R, Reif W. Enzymatische inaktivierung von isonicotinsaure-hydrazid im menschlichen und tierischen Organismus. Arch Exper Pathol Pharmakol 1953; 220: 321.

  20. 20

    Hughes HB, Biehl JP, Jones AP, Schmidt LH. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Am Rev Tuberculosis 1954; 70: 266–73.

  21. 21

    Motulsky AG. Drug reactions, enzymes, and biochemical genetics. JAMA 1957; 165: 835–7.

  22. 22

    Vogel F. Moderne probleme der humangenetik. Ergebnisse der inneren medizin und kinderheilkunde 1959; 12: 65–126.

  23. 23

    Kalow W. Pharmacogenetics. Heredity and the Response to Drugs. Philadelphia, London: W.B. Saunders Company; 1962.

Download references

Author information

Correspondence to Werner Kalow.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kalow, W. Atypical plasma cholinesterase. A personal discovery story: a tale of three cities. Can J Anesth 51, 206 (2004). https://doi.org/10.1007/BF03019096

Download citation

Keywords

  • Cholinesterase
  • Succinylcholine
  • Procaine
  • Cholinesterase Activity
  • Primaquine